Focus on Asthma Care

Back to articles

New recommendations on allergic rhinitis


An updated guideline for pharmacological treatment of seasonal allergic rhinitis recommends monotherapy with an intranasal (I.N.) corticosteroid over combination therapy with an I.N. corticosteroid and oral antihistamine as the initial treatment for patients aged 12 years and older, and clearly states that I.N. corticosteroids should be used over a leukotriene receptor antagonist for patients aged 15 years and older.


Dykewicz MS, et al. Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update. Ann Allergy Asthma Immunol. 2017;119(6):489–511.